The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KRAS in non-small cell lung cancer: Single institution experience—What factors are involved?
 
Idoroenyi Usua Amanam
No Relationships to Disclose
 
Rohan Gupta
No Relationships to Disclose
 
Isa Mambetsariev
No Relationships to Disclose
 
Marianna Koczywas
No Relationships to Disclose
 
Mihaela C. Cristea
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Trovagene
 
Erminia Massarelli
No Relationships to Disclose
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Nektar
Research Funding - Adaptimmune (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
Ravi Salgia
No Relationships to Disclose